Catalyst Wire Dossier Catalyst Wire Dossier

aH5N1 Monovalent H5N1 Influenza Vaccine

H5N1 influenza vaccine, monovalent · Seqirus
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for aH5N1 Monovalent H5N1 Influenza Vaccine, covering 2016-05-09 to 2016-05-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine [Phase 3]

See pricing